DNA
Ginkgo Bioworks Holdings, Inc.Data: 2026-10-23
Quick Stats
Oct 23, 202656.3
AI Score
HOLD0.37
Volume Ratio
Nov 05, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
DNA Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
DNA Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
DNA Options - Sort by Max open Interest (near term)
23rd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DNA Daily Out of Money Options - Sort by Max open Interest (near term)
23rd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DNA Daily In the Money Options - Sort by Max open Interest (near term)
23rd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DNA Most Active Options by Volume(near term)
23rd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DNA Technical Chart Pro Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
DNA Stock Summary
Last updated Oct 23, 2026
DNA is currently trading at $9.99, positioned above its 200-day moving average of $8.53, indicating a long-term uptrend. The stock has a 52-week range of $5.37 to $18.22.
Technical Analysis: The 50-day moving average stands at $9.07, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 46.308, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.042, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates DNA at 56.3/100 with a HOLD recommendation.
DNA (Ginkgo Bioworks Holdings, Inc.) Indicators
Last updated Oct 23, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 46.308 |
| CMF (20) | -0.042 |
| ROC (10) | -24.423 |
| ADX (14) | 49.387 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.149 |
| AROONOSC (14) | -92.857 |
| WILLAMS %R (14) | -95.514 |
| MFI (14) | 9.771 |
DNA Candlestick Patterns
Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.
| Date | Pattern | Signal | 5-Day Hit Rate | Edge vs Baseline | Sample |
|---|---|---|---|---|---|
| Oct 16 | Marubozu (bearish) (contrarian — textbook says the opposite) | Bullish | 56.2% | +3.2 pts | 30540 |
| Oct 14 | Gravestone Doji | Bullish | 55.2% | +2.2 pts | 21200 |
| Oct 14 | Inverted Hammer | Bullish | 56.4% | +3.4 pts | 19834 |
These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.
Ginkgo Bioworks Holdings, Inc. is above both the 50 Day and 200 Day SMA which is considered Bullish.
DNA Moving Averages Analysis
Ginkgo Bioworks Holdings, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Oct 23, 2026
Ginkgo Bioworks Holdings, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Oct 23, 2026
DNA (Ginkgo Bioworks Holdings, Inc.) Simple Moving Averages
Moving Averages are last updated Oct 23, 2026
| Days | MA |
|---|---|
| 10 | 10.68 |
| 20 | 11.5 |
| 30 | 10.46 |
| 50 | 9.07 |
| 100 | 8.84 |
| 200 | 8.53 |
DNA Fundamental Analysis
| P/E (Forward) | -- |
| P/E (Trailing) | -- |
| Market Cap ($) | 674.1 million |
| Earnings/Share ($) | -5.06 |
| Net Profit Margin (%) | -2.1961 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -2.93 |
| EPS Estimate Next Year ($) | -2.9 |
| WallStreet Target Price ($) | 8.00 |
| Most Recent Quarter |
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.